Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

Proven bacterial, viral, conjugate, and E.coli expression platforms support partners from discovery and process development to GMP readiness and clinical manufacturingIntravacc offers four ...

Jakarta: The Ministry of Health aims to develop 15 vaccine antigens domestically by 2029 as part of efforts to achieve ...

Vaccinating against HIV has been a decades-long effort, stymied by the virus’s high mutation rate and mask of human glycans.

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

To test this strategy, the team engineered protein immunogens that mimic key HIV envelope structures known to initiate bnAb ...

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered ...

Researchers at the University of Gothenburg have identified a key protein that allows the virus that causes genital herpes to ...

The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and ...

Qualified Vero Master Cell Bank and Working Cell Bank, originating from WHO banks, are available for purchase, licensing, and use in Intravacc-led CDMO programsIntravacc has used its Vero cell line ...

No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reported ...

New ETEC vaccine technology targeting enterotoxigenic Escherichia coli has been licensed to Valneva after decades of research ...